RegeneRx Seeks Cosmeceutical Partners While Developing Drugs
This article was originally published in The Rose Sheet
Executive Summary
Cash-strapped Maryland biotech firm RegeneRx is in talks with global cosmetics firms to develop products from its drug candidate molecule T?4 and hopes to see revenue from cosmeceuticals by 2010